Philips Ventilator Recall Issued Due to Aerosol Deposits From In-Line Nebulizer Placements
The FDA recall is the latest in a string of problems with Philips breathing devices, which have resulted in thousands of lawsuits in recent years.
The FDA recall is the latest in a string of problems with Philips breathing devices, which have resulted in thousands of lawsuits in recent years.
The manufacturer has become aware of nearly 1,000 reports of the Trilogy Evo ventilator malfunctioning with nebulizers, resulting in three serious injuries.
Recall shortly after Philips agreed to pay $1.1 billion to settle CPAP recall lawsuits filed over toxic sound abatement foam in other breathing machines